PD-0322 Artificial intelligence organ-at-risk dose prediction for high-risk prostate cancer IMRT. (May 2022) - Brodin, P.; Shukla, P.; Hauze, M.; Shulte, L.; Carpenter, C.; Kumar, R.; Bodner, W.; Kalnicki, S.; Garg, M.; Tomé, W.